Pfizer Opens New R&D Site In Cambridge, MA

Pfizer announced that it has opened a new 280,000 sq. ft. Research and Development (R&D) hub in Cambridge, Massachusetts.

The new facility located in Kendall Square will synergize 1,000 colleagues from three key locations and will move the company closer to hospitals, leading academic institutions, and patient organizations. “Having all of our Cambridge-area researchers working closely together in one of the world’s most exciting biomedical ecosystems will allow us to continue our efforts to grow our external collaborations and has the potential to help speed the translation of scientific knowledge into potential medical breakthroughs across areas of unmet need such as lupus, inflammatory bowel disease, kidney disease, type 2 diabetes, muscular dystrophy and Parkinson's disease,” said Mikael Dolsten, President of Worldwide Research and Development at Pfizer.

The new facility, leased from the Massachusetts Institute of Technology (MIT), will be led by Pfizer Group Vice President of BioTherapeutics R&D, Dr. José-Carlos Gutiérrez-Ramos.

Massachusetts Governor Deval Patrick said that the launch of Pfizer’s hub builds on the company’s more than 15 years of commitment to the life sciences community in the State and adds to the broad variety of biomedical firms in Kendall Square. The company also has a research and manufacturing site in Andover as well as its Centers for Therapeutic Innovation (CTI) global headquarters in Boston. CTI focuses on structuring an innovative network for drug discovery to bring new, targeted therapies to patients more quickly.

MIT President Dr. L. Rafael Reif said, “We are thrilled to welcome Pfizer’s new R&D hub to the Kendall Square innovation district… MIT and Pfizer have established a tradition of working together to advance science, research and education, through strategic initiatives like MIT’s Synthetic Biology Center. With this extraordinary core of Pfizer research teams now right next door to our labs at MIT, we can capitalize on the power of proximity to speed progress towards solutions to urgent challenges in human health.”

The company said the grand opening of the new facility will be launched with a ribbon-cutting ceremony in front of the new Main Street facility.